PMOS / PCOS Long Term Health

[Polycystic ovary syndrome--only relevant in reproductive medicine?]

Heim SC, De Geyter C, Siegrist W, Bilz S, Keller U

Published May 1999 Therapeutische Umschau. Revue Therapeutique, 56(5), 271-275
DOI 10.1024/0040-5930.56.5.271 PMID 10409902

Abstract

The Polycystic Ovary Disease (PCOD) is one of the most common endocrine disorders in women with a prevalence of 5%. Affected women often consult a gynecologist because of menstrual irregularities, fertility problems or problems of androgen excess. However, PCOD is a metabolic disorder affecting multiple organs. Studies suggest that those women are at risk for developing several complications such as type II diabetes mellitus, hypertension, dyslipidemia and myocardial infarction. The risk to develop endometrial carcinoma is also elevated. To give adequate treatment to women with PCOD, an interdisciplinary approach of gynecologists together with endocrinologists specialized in metabolic and nutritional disorders at the University of Basel is presented. The work-up for diagnosis and assessment of risk factors is outlined. Goal of this interdisciplinary approach is an adequate evaluation of affected patients and their long-term follow-up to test if proposed interventions as weight loss, treatment of hyperinsulinemia, regulation of menstrual cycle and others can avoid long-term sequelae.

Read the guide

Topics

By this author

Related research

PMOS / PCOS › Long Term Health › Metabolic Risk · Menstrual Cycle › Cycle Disorders › Ovulatory Disturbances
Christian De Geyter
C Geyter
PMID 10409902 10409902 DOI 10.1024/0040-5930.56.5.271 10.1024/0040-5930.56.5.271 Heim et al. 1999, Heim 1999